Publication

Long-term treatment with liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has no effect on β-amyloid plaque load in two transgenic APP/PS1 mouse models of Alzheimer’s disease

PLOS One 11(7):e0158205, 2016

Hansen HH, Fabricius K, Barkholt P, Kongsbak-Wismann P, Schlumberger C, Jelsing J, Terwel D, Termont A, Pyke C, Knudsen LB, Vrang N.

Share this page

Resource Library

Related resources

Plaques in an adult mouse brain

The GLP-1 receptor agonist liraglutide reduces pathology-specific tau phosphorylation and improves motor function in a transgenic hTauP301L mouse model of tauopathy

Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model

Quantitative whole-brain 3D imaging of congophilic parenchymal and vascular amyloid plaque architecture in a transgenic mouse model of Alzheimer’s disease

For further information

Contact us

Gubra

Hørsholm Kongevej 11B
2970 Hørsholm
Denmark

+45 3152 2650